Standard Biotools | FLDM - Pre Tax Profit


Standard Biotools reported $-14.62M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Agilent USD 408M 44M Mar/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Bio-Rad Laboratories USD 542.1M 1.23B Jun/2026
Bruker USD 117M 95.1M Jun/2026
Danaher USD 1.08B 157M Jun/2026
Illumina USD 260M 103M Jun/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Nikon Corporation JPY 1.5B 98.09B Jun/2026
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Revvity USD 187.24M 137.25M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sony JPY 123.8B 376.41B Mar/2026
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Waters USD 356M 444M Jun/2026